Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical Visualization

Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical Visualization

SALT LAKE CITY, Feb. 24, 2026 /PRNewswire/ -- Xenocor, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the new Xenocor Saberscope®, a single-use 5mm articulating laparoscope designed for high definition (HD) visualization during minimally invasive…

Xenocor Announces FDA Clearance of Saberscope

The U.S. Food and Drug Administration (FDA) has cleared the new Xenocor Saberscope, a single-use 5mm articulating laparoscope designed for high-definition (HD) visualization during minimally invasive abdominal (belly) and thoracic (chest) surgical procedures. The Saberscope 5mm articulating disposable laparoscope is designed to deliver consistent, high-quality, full HD imaging while improving operating room workflow, reducing fogging, minimizing…